直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • News
  • Finnegan Facts
  • History
    • Finnegan VISION
    • Finnegan FORWARD
  • Pro Bono
  • Management
    • Pricing & Alternative Fee Arrangements
    • AFA Models We Offer
    • Contingency Fees
    • AI + KM

Commentary

Finnegan Taps Partner from Kirkland to Boost IP Team

June 12, 2026

Finnegan hired Jin Ooi, a life sciences litigator with experience leading cases in the FRAND space. This addition is part of Finnegan’s plan to build a stronger intercontinental team to handle  the increase in global disputes.

Jin told Law360 that his move to Finnegan was a “great moment in time,” given the firm’s ambitions across Europe.

"We're trying to be transformative in our growth, and part of my joining is to bring patent litigation expertise to the firm in the U.K. to complement the full range of IP services that have already been provided by the current London office, and also the wider U.S. practice,” he said.

Jin’s background includes holding a dual degree in law and pharmacology from the University of Sydney. He obtained a postgraduate diploma in intellectual property law from the University of Oxford and has practiced in the federal courts of Australia.

Jin has worked on “all of the leading cases,” concerning disputes over FRAND. He noted that there is a “sort of race” happening over FRAND determinations at the moment, as different courts in the U.K., U.S. and China exhibit different attitudes toward valuations. He said it will take quite some time and international coordination, even between judges, to understand how best to move forward. They perhaps won't always get to the same answer, but there will be a "few different answers," he added.

Jin is also interested in the standards of plausibility in U.K. patent law, which refers to the test that judges use to determine whether it is actually possible to achieve the claimed technical effect in a patent.

Although he calls it a more niche issue, Jin said it has been "significantly up front in many people's minds," adding that the threshold in the U.K. has been set "far too high."

Finnegan’s head of biotechnology and pharmaceutical practice group, Ryan O’Quinn, said life sciences cases are increasingly global battles, making the addition of Jin in London even  more important.

"He really bolsters our life science litigation capabilities in the U.K. and on the continent," Ryan said. "I'm really excited [about] the possibilities he brings to our current clients, and to the clients we're sure that he will bring in."

Read “Finnegan Taps Partner from Kirkland to Boost IP Team”

Tags

Fair Reasonable and Non-Discriminatory (FRAND)

Related Practices

Global IP Enforcement, Litigation, and Trials

Patent Litigation and Trials

Related Industries

Life Sciences

Pharmaceutical

Medical Device and Diagnostics

Related Offices

London

Reston, VA

Related Professionals

Jin Ooi
Partner
London
+44 20 7864 2821
Email
Ryan P. O'Quinn, Ph.D.
Partner
Reston, VA
+1 571 203 2426
Email

Related News

Commentary

Finnegan Hires Kirkland Partner as It Eyes UK Growth

June 8, 2026

Media Mention

Finnegan Hires Kirkland & Ellis Litigator for London Office

June 8, 2026

Press Release

London-Based Life Sciences Litigator Jin Ooi Bolsters Finnegan’s Global IP Litigation Capabilities

June 8, 2026

Commentary

Will the Chicago Cubs Win Their Game Over 'The Rooftop Phenomenon'?

June 8, 2026

Award/Ranking

Forbes Names Finnegan Partner Erika Harmon Arner on its Inaugural 2026 America’s Top Women Lawyers List

June 5, 2026

Award/Ranking

Finnegan Earns Top Rankings in 2026 IAM Patent 1000 Guide; Nearly 60 Attorneys Ranked

May 28, 2026

Commentary

Quince Aims to Have ‘Dupe’ Evidence Shape Ugg Shoe Patent Trial

May 26, 2026

Commentary

New Appellate Opinion in Amazon Biometric Data Case May Signal ‘Narrowing’ Scope of BIPA Litigation, Experts Say

May 20, 2026

Award/Ranking

Finnegan Partner Antje Brambrink Shortlisted for Women in Business Law EMEA Award

May 13, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP